Literature DB >> 2810069

A comparison of parametric with semiparametric analysis of the concentration versus effect relationship of metocurine in dogs and pigs.

S L Shafer1, J R Varvel, G A Gronert.   

Abstract

We investigated the ability of two pharmacokinetic modeling techniques to estimate the equilibration delay (i.e., hysteresis) between plasma drug concentration and observed drug effect. The data were from 20 animals (15 dogs, 5 pigs) receiving an infusion of metocurine, a neuromuscular blocking drug. An effect compartment model was used to model the hysteresis and characterize the relationship between drug concentration and effect. The effect compartment model requires identification of ke0, the rate constant of drug elimination from the effect compartment. Two methods were used to estimate ke0. The first technique was to fit the plasma metocurine concentration-time curve to a two-compartment pharmacokinetic model and then to use this pharmacokinetic model, along with the neuromuscular blockade vs. time curve to estimate ke0 and the parameters of a pharmacodynamic model (the Hill equation). The second technique was to directly estimate ke0 by a recently described semiparametric technique that does not require either a pharmacokinetic or pharmacodynamic model, although it does assume that drug flux to and from the effect compartment is a first-order process. This semiparametric technique only estimates a single parameter, ke0. The results from the new semiparametric analysis technique were similar to the results from the parametric analysis. In the few animals where the results differed, the semiparametric analysis produced a better description of the data.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810069     DOI: 10.1007/bf01061898

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  9 in total

1.  Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models.

Authors:  J D Unadkat; F Bartha; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1986-07       Impact factor: 6.875

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

3.  Simultaneous modeling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamic model.

Authors:  E Fuseau; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1984-06       Impact factor: 6.875

4.  Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation.

Authors:  J C Scott; D R Stanski
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

5.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

6.  Vecuronium kinetics and dynamics in anesthetized infants and children.

Authors:  D M Fisher; K Castagnoli; R D Miller
Journal:  Clin Pharmacol Ther       Date:  1985-04       Impact factor: 6.875

7.  Alcuronium kinetics and plasma concentration-effect relationship.

Authors:  J S Walker; C Shanks; K F Brown
Journal:  Clin Pharmacol Ther       Date:  1983-04       Impact factor: 6.875

8.  Intramuscular ergotamine: plasma levels and dynamic activity.

Authors:  P Tfelt-Hansen; L Paalzow
Journal:  Clin Pharmacol Ther       Date:  1985-01       Impact factor: 6.875

9.  EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil.

Authors:  J C Scott; K V Ponganis; D R Stanski
Journal:  Anesthesiology       Date:  1985-03       Impact factor: 7.892

  9 in total
  5 in total

1.  Do plasma concentrations obtained from early arterial blood sampling improve pharmacokinetic/pharmacodynamic modeling?

Authors:  T M Beaufort; J H Proost; K Kuizenga; M C Houwertjes; U W Kleef; J M Wierda
Journal:  J Pharmacokinet Biopharm       Date:  1999-04

2.  Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.

Authors:  Pierre-Louis Toutain
Journal:  AAPS PharmSci       Date:  2002

Review 3.  [Modern concepts in pharmacokinetics of intravenous anesthetics].

Authors:  T Heidegger; C F Minto; T W Schnider
Journal:  Anaesthesist       Date:  2004-01       Impact factor: 1.041

4.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

5.  Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters.

Authors:  J Ducharme; F Varin; D R Bevan; F Donati
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.